| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/04/2008 | US20080214470 Pin1-Modulating Compounds and Methods of Use Thereof |
| 09/04/2008 | US20080214469 Novel Biologically Active Peptides and Their New Uses |
| 09/04/2008 | US20080214468 Administering a peptide, identified through a phage display library; osteogenesis, cell adhesion/angiogenesis, inhibiting cancer cell metastasis |
| 09/04/2008 | US20080214467 Exendins and Exendin Agonists Modified with Albumin |
| 09/04/2008 | US20080214466 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; pancreatic cancer |
| 09/04/2008 | US20080214465 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 09/04/2008 | US20080214464 Method for the Production of Biologically Active Rhngf |
| 09/04/2008 | US20080214463 Method for cell adhesion and wound healing |
| 09/04/2008 | US20080214462 FIX-Mutant Proteins for Hemophilia B Treatment |
| 09/04/2008 | US20080214461 FVIII-Independent FIX-Mutant Proteins for Hemophilia A Treatment |
| 09/04/2008 | US20080214460 Formulations for cosmetic and wound care treatments with photosensitizers as fluorescent markers |
| 09/04/2008 | US20080214459 Pharmaceutical composition containing sFcyRIIb |
| 09/04/2008 | US20080214458 Administering a modulator that interacts with a neurotransmitter receptor; synapse-specific proteins, Rab3A, NMDA-1, synapsin-1, tetanus toxin receptor, BDNF-receptor and a GABA receptor |
| 09/04/2008 | US20080214457 Isolated peptide, polynucleotide that encodes a peptide that is from 10 to 100 amino acids in length |
| 09/04/2008 | US20080214456 Peptide agent comprising amino acid sequence, proteins, thymosin, or an agent that stimulates production of the peptide agent, an antimicrobially effective preservative, a tonicity agent, a buffer; eye drops |
| 09/04/2008 | US20080214455 5Z)-2-[(2,6-Dichlorophenyl)amino]-5-{[3-(4-morpholinyl)-6-quinoxalinyl]methylidene}-1,3-thiazol-4(5H)-one; inhibiting hYAK3 proteins; autoimmunity, HIV, cancer, drug-induced anemias, myelodysplastic syndrome, aplastic anemia myelosuppression, cytopenia |
| 09/04/2008 | US20080214454 Use of HMGB fragments as anti-inflammatory agents |
| 09/04/2008 | US20080214453 Administering soluble receptor for advanced glycation endproduct (sRAGE) |
| 09/04/2008 | US20080214452 Method for effecting localized, non-systemic and systemic, immunogenic treatment of cancer using crt translocation |
| 09/04/2008 | US20080214451 Chimeric polypeptide; a first domain, a first intracellular loop (i1 loop) or a fragment of a G protein coupled receptor, and a second domain, attached to the first domain, a naturally or non-naturally occurring cell-penetrating, membrane-tethering hydrophobic group |
| 09/04/2008 | US20080214450 Nucleic acid constructs, recombinant expression vectors, and recombinant host cells comprising the polynucleotides |
| 09/04/2008 | US20080214449 Administering N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide |
| 09/04/2008 | US20080214448 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 09/04/2008 | US20080214447 For treatment of hepatitis C |
| 09/04/2008 | US20080214446 Gene Introduction Efficiency Enhancer |
| 09/04/2008 | US20080214445 Contains N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine |
| 09/04/2008 | US20080214444 Semi-synthetic rearranged vancomycin/desmethyl-vancomycin-based glycopeptides with antibiotic activity |
| 09/04/2008 | US20080214443 Compositions and Methods for Control of Insect Infestations in Plants |
| 09/04/2008 | US20080214442 Fucose-containing glycoprotein; kits |
| 09/04/2008 | US20080214441 Administering betaines, lipidic betaines, and antidiabetic agent (metformin) such as sulfonylureas, biguanides, glitazones, a-glucosidase inhibitors, potassium channel antagonists, aldose reductase inhibitors, glucagon antagonists, activators of RXR, insulin therapy or other anti-obesity agents |
| 09/04/2008 | US20080214440 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity |
| 09/04/2008 | US20080214439 Amino acid substituted molecules |
| 09/04/2008 | US20080214438 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content |
| 09/04/2008 | US20080214437 RNA interference; gene therapy; inhalers |
| 09/04/2008 | US20080214436 Methods and compositions for the treatment of cancer or other diseases |
| 09/04/2008 | US20080214435 Leukaemia, lymphoma and myeloma; kits |
| 09/04/2008 | US20080214434 Administering high density lipoprotein |
| 09/04/2008 | US20080213918 Polynucleotides encoding two novel human G-protein coupled receptors, HGPRBMY28 and HGPRBMY29, and splice variants thereof |
| 09/04/2008 | US20080213905 Methods of assessing the need for and the effectiveness of therapy with antioxidants |
| 09/04/2008 | US20080213890 Antibody-avidin fusion proteins as cytotoxic drugs |
| 09/04/2008 | US20080213889 Increasing oocyte maturation via treating oocyte in vitro with gonadotropin hormone and hydrolase inhibitor; treating fertility disorders |
| 09/04/2008 | US20080213888 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 09/04/2008 | US20080213886 Albumin fusion proteins |
| 09/04/2008 | US20080213884 Transgenic cell expressing vector comprising tissue specific regulatory sequences; tissue target gene expression |
| 09/04/2008 | US20080213861 Using targeted gene expression inhibition to treat and prevent viral infection |
| 09/04/2008 | US20080213837 Apo-3 ligand polypeptide |
| 09/04/2008 | US20080213828 Glycoprotein synthesis |
| 09/04/2008 | US20080213822 Methods for diagnosing celiac sprue and reagents useful therein |
| 09/04/2008 | US20080213813 Histone deacetylase inhibitor and use thereof |
| 09/04/2008 | US20080213803 Using proopiomelanocortin neuronal regulatory sequences to identify agents that affects caloric intake, energy expenditure, appetite or food intake; treating eating disorders and/or cachexia |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213778 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/04/2008 | US20080213777 Using malignant brain tumor (MBT) repeat protein (LIN-61) as tool in identifying modulators for prevention and treatment of cell proliferative disorders |
| 09/04/2008 | US20080213760 Compositions and methods for protein isolation |
| 09/04/2008 | US20080213430 nucleic acid constructs, vectors, and host cells; detergents; transgenic plants; animal feeds |
| 09/04/2008 | US20080213427 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides |
| 09/04/2008 | US20080213426 Producing food products from a transgenic non-human animal with increased number of ribs; treating obesity, spinal cord injury, kidney, nervous system and muscular diseases; antisense agents |
| 09/04/2008 | US20080213411 administering an effective amount of a soybean Kunitz trypsin inhibitor to a mammal; no side effects |
| 09/04/2008 | US20080213400 Combinations of Chromium with Antidiabetics for Glucose Metabolism Disorders |
| 09/04/2008 | US20080213397 Nutrient compositions and methods for enhanced effectiveness of the immune system |
| 09/04/2008 | US20080213369 Synthetic platelets |
| 09/04/2008 | US20080213366 Therapeutic Compositions |
| 09/04/2008 | US20080213354 Nanoparticles for protein drug delivery |
| 09/04/2008 | US20080213351 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease |
| 09/04/2008 | US20080213346 Dispersing phospholipid in aqueous solution containing such as human growth hormone and shearing; repeat phospholipid addition and shearing multiple times with stepwise increase in force; efficiency; storage stability |
| 09/04/2008 | US20080213339 Pharmaceutical Composition Containing Indometacin and/or Acemetacin |
| 09/04/2008 | US20080213334 Polyelectrolyte media for bioactive agent delivery |
| 09/04/2008 | US20080213333 Introducing biocompatible material that forms scaffold within bone interior and adminstering augmentation agents to elevate blood levels of anabolic agents; promoting osteoblast activity; fracture repair, osteoporosis; kits |
| 09/04/2008 | US20080213330 Pharmaceutical Compositions Comprising Polyethylene Glycol Having a Molecular Weight of Less Than 600 Daltons |
| 09/04/2008 | US20080213324 Amphiphilic or lipophilic polar functionalized fullerenes and their uses |
| 09/04/2008 | US20080213320 Nutraceutical; digestive enzymes, peptidase, protease, bromelain, papain, amylase, lactase, lipase, hemicellulase; probiotics, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus plantarum, Lactobacillus rhamnosus, Bifidobacterium breve, Bifidobacterium longum; stevia |
| 09/04/2008 | US20080213319 Using chemorepellents and unimodal fugetaxins as therapeutic tool in treatment of cell proliferative disorders |
| 09/04/2008 | US20080213315 free of non-300 kD botulinum toxin type A complexes |
| 09/04/2008 | US20080213314 Combined dna vaccine and biological modifiers for cancer therapy |
| 09/04/2008 | US20080213313 Botulinum toxin treatments |
| 09/04/2008 | US20080213312 Botulinum toxin treatments |
| 09/04/2008 | US20080213311 Neuropeptide Y, kyotorphin, calcitonin-gene related peptides bind receptors; Clostridial toxin HN domain translocates toxin light chain across endosome membrane;Clostridial toxin light chain cleaves a neurosecretory protein; HC domain modified to reduce binding to receptors at neuromuscular junction |
| 09/04/2008 | US20080213310 Use of lytic toxins and toxin conjugates |
| 09/04/2008 | US20080213306 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/04/2008 | US20080213295 Estrogen receptor polypeptide which induces immune respone; for use in treatment and prevention of cell proliferative disorders; antitumor agents |
| 09/04/2008 | US20080213293 Using papillomavirus minor capsid protein as tool in generating neutralizing antibodies which prevent and treat papillomal infection |
| 09/04/2008 | US20080213290 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 09/04/2008 | US20080213288 Glucagon-like peptides (GLP-1); for treatment/prevention of diabetes or autoimmune diseases |
| 09/04/2008 | US20080213287 Method of inhibiting infection by HCV, other flaviviridae viruses, and any other virus that complexes to low density lipoprotein or to very low density lipoprotein in blood preventing viral entry into a cell |
| 09/04/2008 | US20080213286 Composition comprising mastermind domain (MAM) polypeptide for use in treatment of cardiovascular and cell proliferative disorders |
| 09/04/2008 | US20080213285 Secreted chlamydia polypeptides, polynucleotides coding therefor, therapeutic and diagnostic uses thereof |
| 09/04/2008 | US20080213283 Using interleukin-1 inhibitor as therapeutic agent in treatment of spinal cord injury and nervous system disorders; for example, Pralnacasan (VX-740), thalidomide, pentoxifylline, a lazaroid, cyclosporin A |
| 09/04/2008 | US20080213281 Butyrylcholinesterase Variants that Alter the Activity of Chemotherapeutic Agents |
| 09/04/2008 | US20080213279 Blocking Leukocyte Emigration and Inflammation By Interfering With Cd99l2 |
| 09/04/2008 | US20080213276 G-protein coupled receptor specific immunoglobulin for use in treatment of neurodegenerative, spinal cord, psychological disordrers |
| 09/04/2008 | US20080213272 Vegf-related protein |
| 09/04/2008 | US20080213271 Using dopamine receptor specific immunoglobulin to enhance dopaminergic neurotransmission and treat or prevention nervous system and/or neuropsyciatric disorders |
| 09/04/2008 | US20080213264 Immunogens; vaccines; fusion proteins |
| 09/04/2008 | US20080213261 Using tumor necrosis factor specific monoclonal antibody as tool for treatment and prevention of degenerative disc disease |
| 09/04/2008 | US20080213259 Methods for Treating Autoimmune and Chronic Inflammatory Conditions Using Antagonists of CD30 or CD30L |
| 09/04/2008 | US20080213257 Using cytokine antagonist to treat and prevent rheumatoid arthritis and inflammatory bowel diseases |
| 09/04/2008 | US20080213254 Immunoglobulin capable of linking immunoreceptor tyrosine-based activation motif (ITAM) with immunoreceptor tyrosine-based inhibition motif (ITIM) for use in treatment of allergic disorders; gene therapy |
| 09/04/2008 | US20080213253 Combination therapy for the treatment of cancer |
| 09/04/2008 | US20080213250 Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases |
| 09/04/2008 | US20080213248 Methods and Systems for Treating Asthma and Other Respiratory Diseases |